Bausch Health Companies Inc. (TSX: BHC)
Canada
· Delayed Price · Currency is CAD
10.71
+0.07 (0.66%)
Dec 20, 2024, 4:00 PM EST
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.51B USD in the quarter ending September 30, 2024, with 12.15% growth. This brings the company's revenue in the last twelve months to $9.47B, up 10.91% year-over-year. In the year 2023, Bausch Health Companies had annual revenue of $8.76B with 7.79% growth.
Revenue (ttm)
$9.47B
Revenue Growth
+10.91%
P/S Ratio
n/a
Revenue / Employee
$467.39K
Employees
20,270
Market Cap
3.95B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 6.33B |
WELL Health Technologies Corp. | 957.69M |
Curaleaf Holdings, Inc. | 1.83B |
dentalcorp Holdings Ltd. | 1.51B |
Tilray Brands, Inc. | 1.10B |
Sienna Senior Living Inc. | 867.55M |
Cronos Group Inc. | 150.26M |
Extendicare Inc. | 1.42B |
Bausch Health Companies News
- 9 days ago - Contact lens maker Bausch + Lomb says it is exploring sale - Reuters
- 9 days ago - Bausch & Lomb edges higher after confirming sales process - Seeking Alpha
- 9 days ago - Bausch Health Companies Inc (BHC) Responds to Potential Sale Rumors - GuruFocus
- 9 days ago - Bausch + Lomb Responds to Rumors of a Potential Sale - Business Wire
- 9 days ago - Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb - Accesswire
- 10 days ago - Macy's, Dave & Buster's, Bausch + Lomb And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 10 days ago - Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities - Business Wire
- 15 days ago - Bausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News - Seeking Alpha